Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India
about
Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrierInflammatory bowel disease in India - Past, present and futureAlteration of the gut microbiota in Chinese population with chronic kidney diseaseAdvances in treatment of ulcerative colitis with herbs: from bench to bedsideEnteric microbiota leads to new therapeutic strategies for ulcerative colitis.The Natural Antimicrobial Enzyme Lysozyme is Up-Regulated in Gastrointestinal Inflammatory Conditions.Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.Survival of Lactobacillus casei strain Shirota in the intestines of healthy Chinese adults.Gut microbiome, gut function, and probiotics: Implications for health.Inventory of a reservoir: friends & foesThe effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis.Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseasesA reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression.Quantitative Analysis of Intestinal Flora of Uygur and Han Ethnic Chinese Patients with Ulcerative Colitis.Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functionsComposition and function of the pediatric colonic mucosal microbiome in untreated patients with ulcerative colitisRole of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing.Roseburia spp.: a marker of health?The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis.Transforming growth factor β: a master regulator of the gut microbiota and immune cell interactions.Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.The fecal microbiota as a biomarker for disease activity in Crohn's disease.Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC.Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition.Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention.Antibiotic Treatment Induces Long-lasting Changes in the Fecal Microbiota that Protect Against Colitis.Polysaccharides from Chrysanthemum morifolium Ramat ameliorate colitis rats by modulating the intestinal microbiota community.Cryopreservation of artificial gut microbiota produced with in vitro fermentation technology.Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn's Disease and Ulcerative Colitis.Beneficial Effect of Intestinal Fermentation of Natural Polysaccharides
P2860
Q26825483-E5A8FF71-6A7D-416B-ABFF-BF7237F0212BQ28079050-52EEEE98-10A0-4B83-997D-4463FCEBC6BAQ33767631-F090236F-9A6B-4304-AB24-D440513D6AAEQ34366829-736E717B-2600-4C26-AF70-A11965F2F8B2Q34499080-1EB4B4EF-A2B9-4312-B292-9E62B5A73AECQ34533697-B7F2A9DD-0187-4151-B0B3-7A94190797F1Q35271319-4E8CEA5F-EB81-4103-87E1-7AFD379D8580Q35566214-EDF2F8E9-C5E4-4052-BBC6-7192EF453762Q35616074-3D0EBEAE-7210-40CB-84A3-CA075EF06533Q35742141-4BBBFDD3-F6B1-453D-8159-5D9B099506B4Q35824886-6B71CFE9-F5EC-42C4-84C6-1DECA5D043A5Q35858073-B48340B9-1085-4774-B1BC-279AF0454601Q36081100-AC81C9DB-E4AD-48AD-8F38-FCE2D7BEA40DQ36453678-78F7F77E-E055-400C-960A-D9CAE290A3B3Q37157802-B1CF5C15-E66C-4993-85A8-EFAB711755BFQ37303701-F90C5EC1-E821-4EC1-9710-22CF9D750AB6Q38731353-92A51943-5691-49FA-8DE4-419E8382797FQ38764022-56D190BE-074C-457A-8172-D037751D7069Q38968369-4D205C15-55E6-4562-8449-86F6303AD53DQ39316961-27298502-EB82-42B8-9D6C-B89B25EC30C0Q40361105-CF2CCA88-2545-4C78-82FF-2AADE1B3C118Q41447259-F0F4D774-4FC5-4721-BDA1-DF3A80B5D047Q43977750-8EE84571-170C-4450-9A3D-AB47A8913D25Q44967584-E6B9672E-F174-473E-87DE-3C5A58B140B2Q46242554-ABFE3992-4605-4B77-B4F3-956C24D187EDQ47148830-48138A8C-51A5-4C12-9DB6-694EE7D9E5E8Q47171060-2607C6C8-11C3-4008-BC68-B61629AEB9ABQ47341286-FC36E507-497B-4156-B94A-5D7171288348Q49650701-34F9A3AB-B239-4CD4-9B7A-CA9134C6D6CCQ58792658-3E0C7490-62DD-4BA6-8246-05954EF343DB
P2860
Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India
@en
type
label
Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India
@en
prefLabel
Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India
@en
P2860
P356
P1476
Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India
@en
P2093
Jaishree Paul
Vineet Ahuja
P2860
P304
P356
10.3748/WJG.V19.I22.3404
P407
P50
P577
2013-06-01T00:00:00Z